Palmoplantar pustulosis with psoriatic arthritis ineffective to interleukin-17 inhibitors: two patients successfully treated with upadacitinib
AbstractPalmoplantar pustulosis (PPP) is a rare chronic pustular disease. Psoriatic arthritis (PsA) is one of the common manifestations of arthritis in PPP associated with a high burden of disease. The treatment of PPP is difficult and still in the exploratory stage. Only a few cases show that PPP c...
Main Authors: | Zeng-Yun-Ou Zhang, Wen-Yao Mi, Yi-Yi Wang, Wei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2023.2280508 |
Similar Items
-
Case Report: Successful management of refractory palmoplantar pustulosis with upadacitinib
by: Boyun Yang, et al.
Published: (2025-03-01) -
Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patients
by: Na Du, et al.
Published: (2024-11-01) -
Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis
by: Dimitra Koumaki, et al.
Published: (2019-12-01) -
Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
by: Zhang C, et al.
Published: (2023-10-01) -
Successful treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis with tofacitinib: Report of case
by: Yixin Ally Wang, BA, et al.
Published: (2020-02-01)